| Paul D Guisler, MD | |
|
11995 Singletree Ln Ste 500, Eden Prairie, MN 55344-5349 | |
| (952) 595-1301 | |
| (612) 294-4903 |
| Full Name | Paul D Guisler |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 11995 Singletree Ln Ste 500, Eden Prairie, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003806381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD22502 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center, Navicent Health (the) | Macon, GA | Hospital |
| Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Eisenhower Medical Center | Rancho mirage, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Roseburg Radiologists Pc | 0446246003 | 37 |
| Palm Desert Radiology Medical Group Inc | 0749173789 | 109 |
| Golden State Imaging Associates Inc | 1254761315 | 230 |
| Crouse Radiology Associates Llp | 1850387648 | 99 |
| Steuben Radiology Associates Inc | 2961416946 | 33 |
| Virtual Radiologic Professionals Llc | 4981608817 | 355 |
| Singleton Associates Pa | 6305731118 | 691 |
| Radiology Associates Of Macon Pc | 7113817701 | 67 |
| Renaissance Imaging Medical Associates Inc | 7315841756 | 132 |
| North Georgia Radiology | 9032103296 | 26 |
| Gainesville Radiology Group Pc | 9335046382 | 48 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Columbia Lutheran Charities |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1134146939 PECOS PAC ID: 5294643359 Enrollment ID: O20021217000028 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Roseburg Radiologists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700876117 PECOS PAC ID: 0446246003 Enrollment ID: O20040421000595 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Virtual Radiologic Professionals Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932342029 PECOS PAC ID: 4981608817 Enrollment ID: O20090304000842 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Steuben Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679536411 PECOS PAC ID: 2961416946 Enrollment ID: O20150310000811 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Renaissance Imaging Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487608931 PECOS PAC ID: 7315841756 Enrollment ID: O20180212002100 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Palm Desert Radiology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124079868 PECOS PAC ID: 0749173789 Enrollment ID: O20190408002648 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Radiology Associates Of Macon Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679563035 PECOS PAC ID: 7113817701 Enrollment ID: O20190425001255 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Gainesville Imaging Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457553968 PECOS PAC ID: 6507887924 Enrollment ID: O20200127001465 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20200406001436 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Gainesville Radiology Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922037605 PECOS PAC ID: 9335046382 Enrollment ID: O20220317002123 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Central Georgia Mri Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114908522 PECOS PAC ID: 5597752261 Enrollment ID: O20220331002915 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Golden State Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144872052 PECOS PAC ID: 1254761315 Enrollment ID: O20220516001847 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Georgia Magnetic Imaging Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114900545 PECOS PAC ID: 0042205775 Enrollment ID: O20220613000879 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Angelina Diagnostic Radiology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033175302 PECOS PAC ID: 1850380890 Enrollment ID: O20220630002668 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | North Georgia Radiology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922193044 PECOS PAC ID: 9032103296 Enrollment ID: O20220815002801 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619221686 PECOS PAC ID: 8224282926 Enrollment ID: O20221116002021 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Entity Name | Crouse Radiology Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447244587 PECOS PAC ID: 1850387648 Enrollment ID: O20230531002181 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul D Guisler, MD 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344-5349 Ph: (952) 595-1301 | Paul D Guisler, MD 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344-5349 Ph: (952) 595-1301 |
News Archive
Looking to improve organ transplant success, researchers are working to learn more about how an immune molecule, which also protects a fetus, helps protect some transplanted kidneys, and to develop a synthetic version of that molecule that could help more patients.
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Regular exercise improves the ability of overweight, previously inactive children to think, plan and even do math, Georgia Health Sciences University researchers report.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 7 days ago
Norna L. Karp, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Rati N Patel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Jacob Gebrael, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Susanne S. Kim, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Gwendolyn Durgin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Stephen George Fox, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 |